All articles tagged with #lubiprostone
Researchers discovered that a constipation drug, lubiprostone, can slow kidney function decline in CKD patients by improving gut microbiota and mitochondrial health, showing promise as a new treatment approach.
A Phase II clinical trial led by Tohoku University found that lubiprostone, a drug typically used for constipation, can help prevent the decline of kidney function in CKD patients by improving gut microbiota and mitochondrial function, offering a potential new treatment approach.